← Back to catalogue

NYOrtho Padded Mitts

FDA UDI

Class I (US FDA UDI)

by N.y. Orthopedic Usa, Inc.

Identity

Trade Name
NYOrtho Padded Mitts FDA UDI
Generic Name
Limb/torso/head restraint, reusable FDA UDI
Device Name
NYOrtho Padded Mitts protect hands from unwanted picking and scratching. Options include dual-sided padding or one-sided padding combined with breathable mesh fabric to provide additional comfort for hands. Wrist tie closure enables use without arm movement control straps. FDA UDI
Model / Reference
9370 FDA UDI
Description
NYOrtho Padded Mitts protect hands from unwanted picking and scratching. Options include dual-sided padding or one-sided padding combined with breathable mesh fabric to provide additional comfort for hands. Wrist tie closure enables use without arm movement control straps. FDA UDI

Identifiers

Primary DI / UDI-DI
00811677010465 FDA UDI
FDA Product Code
FMQ FDA UDI
GMDN Term
Limb/torso/head restraint, reusable FDA UDI

Classification

Device Class
Class I FDA UDI
Regulation Number
880.6760 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

No

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

No

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

Yes

FDA UDI

Lot / Batch Number

No

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

No

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Limb/torso/head restraint, reusable

NYOrtho Padded Mitts by N.y. Orthopedic Usa, Inc. — Class I — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Limb/torso/head restraint, reusable.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI ee781796-b5b6-49e5-b524-3771c1f95f65 34 fields · synced May 31, 2026